CRS | CERES Regulatory Services

Surviving an FDA Complete Response Letter: Strategies for Success

FDA CRL Wordcloud3

Dear Regulatory Scientists, Receiving an FDA Complete Response Letter (CRL) after submitting a New Drug Application (NDA) or Biologics License Application (BLA) can feel like a major setback. However, with the right approach, this feedback can be a springboard to ultimate approval. Let’s dive into the immediate actions to take, how to convert a CRL […]

Navigating FDA Accelerated Approval Pathways: A Story of Speeding to Success with Fast Track, Breakthrough Therapy and Priority Review Desigations

The FDA Srug Approval Process from nonclinical to clinical development and Phase 1 to Phase 3 Studies leading to approval.

Hello Regulatory Scientists, Let’s take a journey through the world of Accelerated Approval Pathways with Dr. Mike, a passionate regulatory scientist, determined to get his groundbreaking therapy to patients as quickly as possible. In this story, we’ll explore how Dr. Mike leverages Fast Track, Breakthrough Therapy, and Priority Review designations to speed up the approval […]